CRP has been identified as an inflammatory marker that is elevated in NSCLC, and its levels correlate with tumor size and grade but not with NSCLC subtypes, indicating a potential indicator of poorer prognosis and survival outcomes.112. This evidence concerns the gene CRP and neoplasm.